Clinical Trials Browser

Phase 3 × futibatinib × 90 days × Clear all

NCT05615818 2026-05-19

SAFIR-ABC10

Phase 3 Recruiting

Gastrointestinal

Biliary Tract Neoplasms

NCT03784014 2026-04-29

MULTISARC

Phase 3 Completed

Neoplasm Metastasis, Sarcoma